annual EBIT:
-$45.62M-$20.42M(-81.04%)Summary
- As of today (May 31, 2025), KNSA annual earnings before interest & taxes is -$45.62 million, with the most recent change of -$20.42 million (-81.04%) on December 31, 2024.
- During the last 3 years, KNSA annual EBIT has risen by +$111.02 million (+70.88%).
- KNSA annual EBIT is now -566.76% below its all-time high of $9.77 million, reached on December 31, 2022.
Performance
KNSA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$13.27M+$32.57M(+168.77%)Summary
- As of today (May 31, 2025), KNSA quarterly earnings before interest & taxes is $13.27 million, with the most recent change of +$32.57 million (+168.77%) on March 31, 2025.
- Over the past year, KNSA quarterly EBIT has increased by +$29.81 million (+180.23%).
- KNSA quarterly EBIT is now -71.40% below its all-time high of $46.41 million, reached on September 30, 2022.
Performance
KNSA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$15.80M+$29.81M(+65.36%)Summary
- As of today (May 31, 2025), KNSA TTM earnings before interest & taxes is -$15.80 million, with the most recent change of +$29.81 million (+65.36%) on March 31, 2025.
- Over the past year, KNSA TTM EBIT has increased by +$14.74 million (+48.26%).
- KNSA TTM EBIT is now -141.46% below its all-time high of $38.11 million, reached on June 30, 2023.
Performance
KNSA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KNSA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.0% | +180.2% | +48.3% |
| 3 y3 years | +70.9% | +156.9% | +87.9% |
| 5 y5 years | +73.2% | +145.2% | +88.0% |
KNSA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -566.8% | +70.9% | -71.4% | +156.9% | -141.5% | +87.9% |
| 5 y | 5-year | -566.8% | +73.2% | -71.4% | +125.1% | -141.5% | +91.5% |
| alltime | all time | -566.8% | +73.2% | -71.4% | +119.6% | -141.5% | +91.5% |
KNSA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $13.27M(-168.8%) | -$15.80M(-65.4%) |
| Dec 2024 | -$45.62M(+81.0%) | -$19.30M(+99.8%) | -$45.62M(+73.9%) |
| Sep 2024 | - | -$9.66M(+8154.7%) | -$26.24M(-4.6%) |
| Jun 2024 | - | -$117.00K(-99.3%) | -$27.50M(-9.9%) |
| Mar 2024 | - | -$16.54M(<-9900.0%) | -$30.54M(+21.2%) |
| Dec 2023 | -$25.20M(-357.8%) | $81.00K(-100.7%) | -$25.20M(+31.0%) |
| Sep 2023 | - | -$10.93M(+246.4%) | -$19.23M(-150.5%) |
| Jun 2023 | - | -$3.15M(-71.8%) | $38.11M(+74.1%) |
| Mar 2023 | - | -$11.20M(-285.1%) | $21.90M(+124.0%) |
| Dec 2022 | $9.77M(-106.2%) | $6.05M(-87.0%) | $9.77M(-130.2%) |
| Sep 2022 | - | $46.41M(-339.6%) | -$32.41M(-70.4%) |
| Jun 2022 | - | -$19.37M(-16.9%) | -$109.48M(-16.2%) |
| Mar 2022 | - | -$23.32M(-35.5%) | -$130.67M(-16.6%) |
| Dec 2021 | -$156.64M(-0.5%) | -$36.13M(+17.8%) | -$156.64M(-9.7%) |
| Sep 2021 | - | -$30.67M(-24.4%) | -$173.40M(-6.7%) |
| Jun 2021 | - | -$40.55M(-17.7%) | -$185.95M(+4.9%) |
| Mar 2021 | - | -$49.28M(-6.8%) | -$177.26M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$157.36M(-7.4%) | -$52.90M(+22.4%) | -$157.36M(+14.8%) |
| Sep 2020 | - | -$43.22M(+35.6%) | -$137.05M(+10.3%) |
| Jun 2020 | - | -$31.86M(+8.4%) | -$124.27M(-5.6%) |
| Mar 2020 | - | -$29.39M(-9.8%) | -$131.70M(-22.5%) |
| Dec 2019 | -$169.96M(+57.1%) | -$32.58M(+7.0%) | -$169.96M(-6.4%) |
| Sep 2019 | - | -$30.45M(-22.5%) | -$181.52M(+2.4%) |
| Jun 2019 | - | -$39.29M(-41.9%) | -$177.23M(+11.1%) |
| Mar 2019 | - | -$67.65M(+53.3%) | -$159.47M(+47.4%) |
| Dec 2018 | -$108.16M(+65.4%) | -$44.13M(+68.7%) | -$108.16M(+11.8%) |
| Sep 2018 | - | -$26.16M(+21.5%) | -$96.74M(+11.4%) |
| Jun 2018 | - | -$21.53M(+31.7%) | -$86.83M(+13.2%) |
| Mar 2018 | - | -$16.34M(-50.0%) | -$76.69M(+17.3%) |
| Dec 2017 | -$65.40M(+172.5%) | -$32.71M(+101.3%) | -$65.40M(+100.1%) |
| Sep 2017 | - | -$16.25M(+42.6%) | -$32.69M(+98.8%) |
| Jun 2017 | - | -$11.39M(+125.7%) | -$16.44M(+225.7%) |
| Mar 2017 | - | -$5.05M | -$5.05M |
| Dec 2016 | -$24.00M | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual EBIT year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly EBIT year-on-year change?
- What is Kiniksa Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM EBIT year-on-year change?
What is Kiniksa Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of KNSA is -$45.62M
What is the all time high annual EBIT for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual earnings before interest & taxes is $9.77M
What is Kiniksa Pharmaceuticals annual EBIT year-on-year change?
Over the past year, KNSA annual earnings before interest & taxes has changed by -$20.42M (-81.04%)
What is Kiniksa Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of KNSA is $13.27M
What is the all time high quarterly EBIT for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly earnings before interest & taxes is $46.41M
What is Kiniksa Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, KNSA quarterly earnings before interest & taxes has changed by +$29.81M (+180.23%)
What is Kiniksa Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of KNSA is -$15.80M
What is the all time high TTM EBIT for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM earnings before interest & taxes is $38.11M
What is Kiniksa Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, KNSA TTM earnings before interest & taxes has changed by +$14.74M (+48.26%)